Breaking news: Foreign funds continue accumulate Harta and Topglove from the expected ASP improvements, improve in book to order and plant capacity utilisation
Breaking news: Harta expected to show QR loss result, the ASP improvement will only see in next QR with breakeven or small loss. Stock price expected remain consolation
"Dreaming is essential for a human being. Without dreams, you will lose interest in life and finally hate to live life. You will be bored and tired of the same monotonous routines of your daily life and will not even find interest in the most exciting things. Only with dreams, will you find a purpose to live your life."
Gua caya sama lu lah Endgame but if you were to widen your horizon to certain extent, She will eventually go back to where she is suppose to be if history is any guidance. Don't tell me She doesn't have any economics moats and all that nonsense. Look around you all the businesses in the world who doesn't have rivals and competition
Breaking news: Medical sectors commented they still prefer Malaysia glove due to high quality compared with China glove with lower ASP. When they performed sourcing criteria, China glove still far behind to meet the medical stringent requirements whereby Malaysia glove Harta and Kossan always exceeded requirements criteria.
$KLSE-HARTA - Finally not another sell call? Updates from CIMB Corporate Day
There's really a lot to digest from CIMB's corp day. This time let's take a look at the presentation by Hartalega to learn about their latest updates.
1. They continue to see strong headwinds heading into 2H FY23.
2. ASP is expected to further decline from USD 24 to USD 20, and stabilise at that level.
3. ASP hikes will be challenging due to the same reasons discussed about many times already.
4. Customer inventory is expected to ease in the next 2 quarters however it remains to be seen whether there will be a significant pick-up in demand after that since customers are not buying aggressively yet.
In the near term...
5. Rising operation costs will continue to pressure margins however this is partially offset by decreasing raw material prices.
6. in Q2 FY 23, utilisation rate was 49%, which is below pre-covid utilisation of around 75-80%. They estimate that the industry average utilisation rate is around 50% too. Harta expects utilisation to maintain around this range for the next few quarters.
7. Harta thinks that it could potentially be in the red for the next 1 or 2 quarters.
8. They will focus on cost management, operational efficiencies, and scale up automation initiatives across their operations.
In the longer term...
9. Harta expects global glove demand to grow at an average 9% annually, similarly to pre covid for the past 10 years.
10. Intense competition and oversupply is expected to persist in CY 2023. Thus, Harta is also slowing down expansion plans in NGC 1.5 as well as their Sepang plants. The commissioning of 2 lines in NGC 1.5 is expected around 2H FY23, and subsequent lines staggered across the next 2-3 years. The construction of the next 2 plants will be delayed as necessary.
11. Most of the other glove players are also slowing down expansion plans.
12. They estimate the total current global supply is 500bn pcs, while demand is about 252bn in 10M CY 22. The oversupply situation is expected to take around 1-2 more years to abate before earnings can return to pre-pandemic levels.
13. Harta plans to maintain its OEM business and diversify its customer base, while implementing an OBM strategy into multiple medical device distribution company across AsiaPac. They are also considering M&As.
Current Landscape...
14. Glovemakers from China have also slowed and cancelled expansion plans. Harta expects the aggressive price cuts so far will slow down as current ASP will likely lead to losses for the Chinese players as well.
15. Harta says that the Chinese players can only cut as they did because they were allowed to use coal as a source of energy which is cheaper. Should the government policy change and prohibit the usage of coal, the advantage would be negated. Harta expects to maintain their competitive advantage due to their better quality product as well as the geopolitical tensions surrounding China.
16. CIMB believes current valuation can be supported as it is already 20% discount to the sector, long term demand for gloves, Harta's leading technology and margins, as well as their strong net cash position.
Walaoer , still got people dreaming with glove mania, now is 2023 , pandemic over already bro , utilities stock like ranhill or wafer foundry stock like dnex will be the king !
Everything has changed but the stubborn old school mindset still dreaming in glove mania 2020 ! Latest qr will bring harta become penny stock . Tg = below 50 sens , kossan = 60 sens , supermax will facing huge loss from USA site , how to fight with China good cheap glove ????
Penny stock eh? Let's see. What if it didnt become penny stock? Will you sell to me at penny stock price? Got to put your money where your mouth is at right? Mr Japanese- san.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Endgame
729 posts
Posted by Endgame > 2023-01-12 13:25 | Report Abuse
Breaking news: Foreign funds continue accumulate Harta and Topglove from the expected ASP improvements, improve in book to order and plant capacity utilisation